drugset
drugset / Trial / NCT00579995

A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate

NCT00579995 ↗

Terminated 41 enrolled University of Nebraska
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to compare the efficacy of oral N-acetylcysteine and intravenous sodium bicarbonate for the prevention of Contrast-Induced Nephropathy (CIN) after cardiac catheterization.

Timeline

Start
2005-05-01
Primary completion
2010-04-08
Completion
2010-04-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 600 mg Oral
Comparator sodium bicarbonate Diagnostic / imaging agent 1 ml Intravenous

Indications

No indication recorded.